Germany vs Sri Lanka: Women's share of population ages 15+ living with HIV
Germany
20.5%
in 2024
Sri Lanka
19.5%
in 2024
Germany rank
133rd
Sri Lanka rank
136th
Women's share of population ages 15+ living with HIV over time
- Germany
- Sri Lanka
How they compare
Germany currently reports 20.5% against 19.5% in Sri Lanka, a difference of 1.0%.
That makes Germany's figure about 1.1 times Sri Lanka's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Sri Lanka ahead.
Germany ranks 133rd and Sri Lanka ranks 136th of 172 countries.
Sri Lanka has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Germany | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 17.7% | 20.6% | 2.9% | Sri Lanka |
| 2000s | 18.4% | 26.6% | 8.2% | Sri Lanka |
| 2010s | 18.0% | 30.9% | 12.9% | Sri Lanka |
| 2020s | 19.7% | 22.0% | 2.3% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher women's share of population ages 15+ living with hiv, Germany or Sri Lanka?
- Germany, at 20.5% against 19.5% in Sri Lanka as of 2024.
- What is the difference in women's share of population ages 15+ living with hiv between Germany and Sri Lanka?
- 1.0%, with Germany ahead.
- How many years of comparable data are there for Germany and Sri Lanka?
- 35 years are reported by both, from 1990 to 2024.
- How do Germany and Sri Lanka rank globally for women's share of population ages 15+ living with hiv?
- Germany ranks 133rd and Sri Lanka ranks 136th of 172 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Women's share of population ages 15+ living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.